- According to estimates from 15 analysts, Quest Diagnostics Incorporated stock's average price target has risen from $239.47 to $241.73, with forecasts ranging from $215 to $265 per share
- Based on the Jul. 23 closing price, the updated target implies approximately 6% potential upside
- Consensus rating remains at “Buy” across 21 covering analysts, with 10 Buys, 11 Holds and 0 Sells
Explore more price target data and ratings for Quest Diagnostics Incorporated on the , and track all previous and future analyst recommendations for Quest Diagnostics Incorporated in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.